References
- Bianchine J. R. Drugs for Parkinson's disease, spasticity, and acute muscle spasms. The Pharmacological Basis of Therapeutics (2nd edition), A. G. Gilman, L. S. Goodman, T. W. Rall, F. Murad. Macmillan Publishing Company, New York 1985; 475–481
- Boukhris W., Kouassi E., Descotes J., Cordier G., Revillard J. P. Impaired T-dependent immune response in L-dopa treated BALB/c mice. Journal of Clinical Laboratory Immunology 1987; 23: 185–189
- Buu N. T., Duhaime J., Kuchel O. Effects of L-dopa on the concentration of free and sulfoconjugated catecholamines in plasma, cerebrospinal fluid, urine, and central and peripheral nervous system tissues of the rat. Journal of Neurochemistry 1985; 44: 787–792
- Felten D. L., Felten S. Y., Carlson S. L., Olschowska J. A., Livnat S. Innervation of lymphoid tissue. Journal of Immunology 1985; 135: 755s–765s
- Hornykiewicz O. Parkinson's disease. Disorders of Neurohumoral Transmission, T. J. Crow. Academic Press, London 1982; 121–141
- Janković B. D., Kuši D. Autoimmune features of Parkinson's disease. Neuroimmune Networks: Physiology and Diseases, E. J. Goetzl, N. H. Spector. Alan R. Liss, Inc, New York 1989; 259–267
- Kouassi E., Boukhris W., Descotes J., Zukervar P., Li Y. S., Revillard J. P. Selective T cell defects induced by dopamine administration in mice. Immunopharmacology and Immunotoxicology 1987; 9: 477–488
- Kouassi E., Li Y. S., Flacher M., Revillard J. P. Cyclic adenosine 3′, 5′-monophosphate response to dopamine in mouse lymphoid cells and cell lines. Life Sciences 1987; 40: 2385–2392
- LeFür G., Phan T., Uzan A. Identification of Stereospecific (3H) Spiroperidol binding sites in mammalian lymphocytes. Life Sciences 1980; 26: 1139–1148
- Papavasiliou P. S., Gotzias G. C., Duby S. E., Steck A. J., Fehling C., Bell M. A. Levodopa in Parkinsonism: potentiation of central effects with a peripheral inhibitor. New England Journal of Medicine 1972; 285: 8–12
- Pletscher A., Bartholini G. Selective rise in brain dopamine by inhibition of extracerebral levodopa decarboxylation. Clinical Pharmacology and Therapeutics 1971; 12: 344–352
- Seeman P. Brain dopamine receptors. Pharmacological Review 1981; 32: 229–313
- Stefano G. B., Zhao X., Bailey D., Metlay M., Leung M. K. High affinity dopamine binding to mouse thymocytes and Mytilus edulis (Bivalvia) hemocytes. Journal of Neuroimmunology 1989; 21: 67–74
- Stepien H., Kunert-Radek J., Karašek E., Pawlikowski M. Dopamine increases cyclic AMP concentration in the rat spleen lymphocytes in vitro. Biochemical and Biophysical Research Communications 1981; 101: 1057–1063